Enveda Biosciences has filed a notice of an exempt offering of securities to raise $62,459,761.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Enveda Biosciences is raising $62,459,761.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Viswa Colluru played a key role…